These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37172748)

  • 1. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
    Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
    Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
    Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
    Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
    Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
    Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
    Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide proton transfer-weighted and arterial spin labeling imaging may improve differentiation between high-grade glioma recurrence and radiation-induced brain injury.
    Chen L; Huang L; Zhang J; Li S; Li Y; Tang L; Chen W; Wu M; Li T
    Heliyon; 2024 Jun; 10(11):e32699. PubMed ID: 38961946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
    Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
    Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
    Lin L; Xue Y; Duan Q; Sun B; Lin H; Huang X; Chen X
    Oncotarget; 2016 Oct; 7(42):69051-69059. PubMed ID: 27655705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.
    Xu Y; Wan Q; Ren X; Jiang Y; Wang F; Yao J; Wu P; Shen A; Wang P
    Magn Reson Imaging; 2024 Feb; 106():104-109. PubMed ID: 38135260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer imaging-arterial spin labeling mismatch: a new imaging biomarker for pilocytic astrocytoma.
    Rajendran A; Natesan C; Jawahar P; Patil S; Chilukuri S; Ghosh S; Kumar R; Jalali R
    Sci Rep; 2023 Sep; 13(1):16377. PubMed ID: 37773324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Oct; 34(10):6820-6830. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI.
    Hou H; Diao Y; Yu J; Xu M; Wang L; Li Z; Song T; Liu Y; Yuan Z
    NMR Biomed; 2023 Jan; 36(1):e4821. PubMed ID: 36031734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ovarian endometriotic cysts in cystic lesions of the ovary by amide proton transfer-weighted imaging and R2∗ mapping.
    Li Y; Lu X; Chen L; Zhang Q; Wang N; Wang J; Lin L; Hu G; Zhang Y; Liu A
    Clin Radiol; 2023 Feb; 78(2):e106-e112. PubMed ID: 36334944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial Spin Labeling and Amide Proton Transfer Imaging can Differentiate Glioblastoma from Brain Metastasis: A Systematic Review and Meta-Analysis.
    Teng M; Wang M; He F; Liang W; Zhang G
    World Neurosurg; 2024 Feb; 182():e702-e711. PubMed ID: 38072160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
    Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
    J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
    Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
    Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.